Index
By TNW
About Index
Trending news
Analyze
Pricing
Sign up or sign in
Nektar Therapeutics
Work at Nektar Therapeutics?
Add yourself to this profile
3726
Nektar Therapeutics
Nektar is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates designed to improve the benefits of drugs for patients.
Edit Profile
nektar.com
Technology
>
Biotechnology
B2c
Founded in
1990
Raised
$45M
More info
Elsewhere
Also headquartered in San Francisco
Twitter
Uber
Instagram
Airbnb
Lyft
Salesforce
Reddit
Fitbit
TechCrunch
Slack
Companies in the same industry
MedAvail
BioNano Genomics
Cerevast
EffRx
Bikanta
GrayBug
Pulmatrix
Pennington Biomedical Research Center
AmnioChor
LUMA D.A.C.
Alexa global traffic share
Twitter followers
Overview
Funding
2
Investments
1
Add info
Latest funding
Post-IPO equity
$20,000,000
Venture capital
$25,000,000
AstraZeneca
Employees
Team size
500+
Locations
HQ
San Francisco
,
United States
Headquarters
$20,000,000
Post-IPO equity
Xconomy
Nektar Therapeutics Gets $20M in Daiichi Deal For Breast Cancer Drug
Health
The Motley Fool
Why Nektar Therapeutics Inc Is Dropping Today
The Motley Fool
Here's Why Nektar Therapeutics Inc. Rose 19% in March
The Motley Fool
Why Nektar Therapeutics Skyrocketed 30% Higher in October --
Stock markets
Health
Twitter
Uber
Instagram
Airbnb
Lyft
Salesforce
Reddit
Fitbit
TechCrunch
Slack
MedAvail
BioNano Genomics
Cerevast
EffRx
Bikanta
GrayBug
Pulmatrix
Pennington Biomedical Research Center
AmnioChor
LUMA D.A.C.